» Download Public Reports
17 reports
- Country report
- November 2011
- 3 pages
- by Corporation
... In product development and expanded sales activities in growth markets. Agenda 2013 also encompasses a realignment of the radiation therapy business unit that will likely include evaluating measures ...
December 2012
... pain therapies as part of providing acute inpatient care are placed under increasing pressure in ensuring that the quality of care remains high while the costs incurred remain low. The purpose ...
March 2011
... With non- seasonal sales (eg for dust mites or pet allergies) or those with sales that coincide with the allergy season. Source: allergy therapeutics, edison investment research allergy therapeutics ...
March 2011
... Additional therapy to expand currently limited treatment options, increase efficacy of available chemotherapy and prolong survival significant therapeutic potential in a variety of solid tumor ...
December 2011
... Of advanced proton solutions (holdings) ltd (aps) as a major participant in the development and operation of proton beam therapy centres for cancer treatment internationally. I am pleased to report progress ...
December 2011
... That will complement the approval of nanotherm therapy as a medical device. In 2012, the company expects a slight loss reduction compared to the previous year due to the restructuring program initiated in 2011 ...
April 2010
... Penetration in the german and northern european markets. The acquisition secures zoobiotic S position as the dominant player in the world larval therapy market. Zoobiotic S investors include partnerships (uk ...